Why the Trump PBM Reform Plan Has Promise and Why Democrats Oppose IT

by: Robert Goldberg |
02/13/2019

I wrote two op-eds that just happened to be published the same day (today)

The first one explains whyTrump's Prescription Drug Price Reform is Promising.

Soaking the Sick to Make the Rich Even Richer discusses how Democrat opposition to the Trump proposal has led legislators from that party propose giving PBMs more control over access to medicines.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Why the Trump PBM Reform Plan Has Promise and Why Democrats Oppose IT

Latest from CMPI

Coronavirus: America’s drug supply needs a refill

Prescription for Failure: The Ills of Socialized Medicine (CPAC 2020)

How to eliminate surprise medical bills

Keep Canadian drugs out of U.S. medicine cabinets

Blog Roll

Categories